BUB1 Antikörper (Budding Uninhibited By Benzimidazoles 1 Homolog (Yeast)) (AA 281-419)

Details for Product anti-BUB1 Antibody No. ABIN2477744, Anbieter: Anmelden zum Anzeigen
Antigen
  • bub1a
  • bub1l
  • hbub1
  • xbub1
  • BUB1A
  • BUB1L
  • hBUB1
  • AL022991
  • Bub1a
  • C80208
  • D2Xrf87
  • BUB1 mitotic checkpoint serine/threonine kinase
  • BUB1, mitotic checkpoint serine/threonine kinase
  • BUB1
  • bub1
  • Bub1
Epitop
AA 281-419
15
15
13
9
9
8
8
7
4
4
3
3
2
2
2
2
1
1
Reaktivität
Human
158
53
35
1
Wirt
Maus
111
47
Klonalität (Klon)
Monoklonal ()
Konjugat
Dieser BUB1 Antikörper ist unkonjugiert
4
4
4
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Applikation
Immunofluorescence (IF), Immunoprecipitation (IP), Western Blotting (WB)
120
81
51
41
32
18
17
13
12
3
2
1
1
1
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Immunogen Recombinant protein corresponding to amino acids 281-419 of human Bub1 protein.
Klon 14H5
Isotyp IgG1
Produktmerkmale Purified IgG
Reinigung Purified
Plasmids, Primers & others Plasmide, Primers & weitere BUB1 products on genomics-online (e.g. as negative or positive controls)
Antigen Budding Uninhibited By Benzimidazoles 1 Homolog (Yeast) (BUB1)
Andere Bezeichnung BUB1 (BUB1 Antibody Abstract)
Gen-ID 699
UniProt O43683
Applikations-hinweise Optimal working dilution should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1.0 mg/mL
Produkt verwendet in: Meraldi, Sorger: "A dual role for Bub1 in the spindle checkpoint and chromosome congression." in: The EMBO journal, Vol. 24, Issue 8, pp. 1621-33, 2005 (PubMed).

Morrow, Tighe, Johnson, Scott, Ditchfield, Taylor: "Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20." in: Journal of cell science, Vol. 118, Issue Pt 16, pp. 3639-52, 2005 (PubMed).

Allgemeine Veröffentlichungen Vlasveld, Rankin, Hekman, Rodenhuis, Beijnen, Hilton, Dubbelman, Vyth-Dreese, Melief: "A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects." in: British journal of cancer, Vol. 65, Issue 5, pp. 744-50, 1992 (PubMed).

Haben Sie etwas anderes gesucht?